IBKS No2 SPAC (204840) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.014x

Based on the latest financial reports, IBKS No2 SPAC (204840) has a cash flow conversion efficiency ratio of -0.014x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-288.62 Million ≈ $-195.60K USD) by net assets (₩20.01 Billion ≈ $13.56 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

IBKS No2 SPAC - Cash Flow Conversion Efficiency Trend (2015–2024)

This chart illustrates how IBKS No2 SPAC's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read how much debt does IBKS No2 SPAC carry for a breakdown of total debt and financial obligations.

IBKS No2 SPAC Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of IBKS No2 SPAC ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Baolong International Co Ltd TW:1906	0.154x
SundayToz Corp KQ:123420	0.026x
Sea & Land Integrated Co TWO:5603	0.023x
C-Tech United TWO:3625	-0.090x
ARRAS MINERALS CORP. F:9RJ	N/A
Widodo Makmur Unggas Tbk PT JK:WMUU	-0.001x
Silvano Fashion Group AS WAR:SFG	0.016x
Universal Textile Co Ltd TW:1445	0.037x

Annual Cash Flow Conversion Efficiency for IBKS No2 SPAC (2015–2024)

The table below shows the annual cash flow conversion efficiency of IBKS No2 SPAC from 2015 to 2024. For the full company profile with market capitalisation and key ratios, see 204840 market cap overview.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩19.67 Billion ≈ $13.33 Million	₩-4.65 Billion ≈ $-3.15 Million	-0.236x	+22.80%
2023-12-31	₩12.28 Billion ≈ $8.32 Million	₩-3.76 Billion ≈ $-2.55 Million	-0.306x	-288.18%
2022-12-31	₩16.09 Billion ≈ $10.90 Million	₩-1.27 Billion ≈ $-859.85K	-0.079x	+41.51%
2021-12-31	₩16.85 Billion ≈ $11.42 Million	₩-2.27 Billion ≈ $-1.54 Million	-0.135x	+27.62%
2020-12-31	₩14.31 Billion ≈ $9.70 Million	₩-2.67 Billion ≈ $-1.81 Million	-0.186x	+58.96%
2019-12-31	₩2.36 Billion ≈ $1.60 Million	₩-1.07 Billion ≈ $-726.36K	-0.454x	+6.69%
2018-12-31	₩7.82 Billion ≈ $5.30 Million	₩-3.80 Billion ≈ $-2.58 Million	-0.486x	+24.43%
2017-12-31	₩5.94 Billion ≈ $4.02 Million	₩-3.82 Billion ≈ $-2.59 Million	-0.644x	-38.10%
2016-12-31	₩8.57 Billion ≈ $5.81 Million	₩-3.99 Billion ≈ $-2.71 Million	-0.466x	-161.72%
2015-12-31	₩3.18 Billion ≈ $2.16 Million	₩2.40 Billion ≈ $1.63 Million	0.755x	--

About IBKS No2 SPAC

KQ:204840 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$52.33 Million

₩77.22 Billion KRW

Market Cap Rank

#21768 Global

#1424 in Korea

Share Price

₩1000.00

Change (1 day)

+1.01%

52-Week Range

₩990.00 - ₩1320.00

All Time High

₩8655.23